AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL
· Real-Time Price · USD
2.31
0.17 (7.94%)
At close: Jun 03, 2025, 3:59 PM
2.41
4.10%
Pre-market: Jun 04, 2025, 06:53 AM EDT
AbCellera Biologics Revenue
AbCellera Biologics reported an annual revenue of $28.83M, reflecting a -24.17% growth. For the quarter ending March 31, 2025, AbCellera Biologics generated $4.24M in revenue.
Revenue (ttm)
$28.83M
Revenue Growth
-24.17%
Price / Sales Ratio
29.91
Revenue / Employee
$48.38K
Employees
596
Market Cap
690.99M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|